RxDoctor Payments Data

Dyana Manning, PA

Physician Assistant · Lowville, NYNPI 1215379649

Payments from drug & device makers

$2,209in general payments, 2019–2025

Across 127 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$466
  • Novo Nordisk$245
  • GSK$165
  • Pfizer$164
  • Amgen$146
  • Otsuka America Pharmaceutical, Inc.$112
  • plus $911 from 20 others

What the payments were for

  • Food & beverage$2,209100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,209 in reported general payments places this provider in the 85th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$29,219
Medicare patients
132
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$66,242
JardianceEmpagliflozin28$37,424
OzempicSemaglutide27$31,982
TrulicityDulaglutide19$31,771
JanumetSitagliptin Phos/Metformin Hcl12$19,103
Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine14$4,257
Venlafaxine Hcl ErVenlafaxine Hcl34$3,785
Levothyroxine Sodium105$1,875
Valsartan49$1,712
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic21$1,512
Rosuvastatin Calcium117$1,495
Albuterol Sulfate HfaAlbuterol Sulfate21$1,408
Pregabalin21$1,366
Potassium Chloride43$1,194
Bisoprolol Fumarate33$1,172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$164$66,24246 claims
Boehringer IngelheimJardiance$26$37,42428 claims
Novo NordiskOzempic$245$31,98227 claims
Lilly USA, LLCTrulicity$102$31,77119 claims
MerckJanumet$43$19,10312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Lowville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →